Shield Bio Company
Shield Bio - using ultra-fast sequencing to prevent antibiotic resistance
Investors
%20.jpg)
Investors Number:
20
Industry:
Deep Diagnostics
Employee Number:
11-50
Total Funding:
$12.1M
Technology:
Сancer Diagnostics
Last Funding Type:
Series A
Investor Type:
For Profit
Estimated Revenue:
Less than $1M
Headquarters:
San Jose, California, United States
Funding Status:
Early Stage Venture
Founded Date:
04.05.2016